Replies to post #156798 on Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Good point. Many CTIX investors do not understand the impact positive studies for Brilacidin in Oral Mucositis and Ulcerative Proctititis will have.

Outstanding results in these studies will lead to clinical trials for other inflammatory bowel diseases such as Crohn's disease and Ulcerative Colitis.These unfortunate disorders are chronic, recurrent problems which produce debilitating symptoms and require frequent treatment. Unlike Ulcerative Proctitis and Oral Mucosides they are common with an estimated million suffers in the United States and millions more worldwide.

And while this potential will not produce a near term rise in CTIX's share price, it could be a nice bargaining chip.

http://www.cdc.gov/ibd/ibd-epidemiology.htm

GLTA, Farrell

[MinnieM]

You are absolutely correct. ;)






In Reply to 'Jhawker'
I am more of a coffee guy but I think B-OM results or B-UP results could have a big impact.